In this study, while MT-1 increased PrKD kinase activity presumptively due to de-repression by decreased c-Myc protein function, we were able demonstrate decrease in c-Myc function in the PDX tumor tissue, although we were unable to demonstrate lower protein levels of c-Myc despite MT-1 treatment in the PDX tumors. This evidence concerns the gene MYC and neoplasm.